Spi-1005 Updates 2024. Seattle, washington — sound pharmaceuticals, a biopharmaceutical company, has announced the completion of enrollment in its phase 3. Sound pharmaceuticals is pleased to announce that the fda's division of neurology products has granted its request for fast track designation (ftd) involving.
(spi) is pleased to announce a cooperative grant award from the national center. This review summarizes the published.
06 Apr, 2021, 09:15 Et.
11 may, 2022, 09:10 et.
(Spi) Is Pleased To Announce That Is Has Received A $1.1M.
Seattle, washington — sound pharmaceuticals, a biopharmaceutical company, has announced the completion of enrollment in its phase 3.
Seattle, Washington — Sound Pharmaceuticals Has Announced That It Has Enrolled The First Patient In Its Phase 3 Clinical Trial Involving Spi.
Images References :
(Spi) Is Pleased To Announce That Is Has Received A $1.1M.
28 jul, 2022, 09:15 et.
Seattle, Washington — Sound Pharmaceuticals Has Announced That It Has Enrolled The First Patient In Its Phase 3 Clinical Trial Involving Spi.
06 apr, 2021, 09:15 et.
Seattle, Washington — Sound Pharmaceuticals, A Biopharmaceutical Company, Has Announced The Completion Of Enrollment In Its Phase 3.